This study is designed to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reduction to improve right ventricular (RV) function and reverse RV remodeling in patients with PAH.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Jimmy Ford
Medicine-Pulmonary
Clinical or Medical
Interventional
Chronic Conditions
Heart and Circulation
Lungs and Breathing
Rare Diseases
22-1183
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
